Literature DB >> 22179064

Inactivation of high and low pathogenic avian influenza virus H5 subtypes by copper ions incorporated in zeolite-textile materials.

Kunitoshi Imai1, Haruko Ogawa2, Vuong Nghia Bui3, Hiroshi Inoue4, Jiro Fukuda4, Masayoshi Ohba4, Yu Yamamoto5, Kikuyasu Nakamura5.   

Abstract

The effect of cotton textiles containing Cu(2+) held by zeolites (CuZeo-textile) on the inactivation of H5 subtype viruses was examined. Allantoic fluid (AF) containing a virus (AF virus) (0.1 ml) was applied to the textile (3×3-cm), and incubated for a specific period at ambient temperature. After each incubation, 0.9 ml of culture medium was added followed by squeezing to recover the virus into the medium. The recovered virus was titrated using Madin-Darby canine kidney (MDCK) cells or 10-day-old embryonated chicken eggs. The highly pathogenic H5N1 and the low pathogenic H5N3 viruses were inactivated on the CuZeo-textile, even after short incubation. The titer of A/chicken/Yamaguchi/7/04 (H5N1) in MDCK cells and in eggs declined by >5.0 log(10) and 5.0 log(10), respectively, in 30 s. The titer of A/whooper swan/Hokkaido/1/08 (H5N1) in MDCK cells declined by 2.3 and 3.5 in 1 and 5 min, respectively. When A/whistling swan/Shimane/499/83 (H5N3) was treated on the CuZeo-textile for 10 min, the titer declined by >5.0 log(10) in MDCK cells and by >3.5 log(10) in eggs. In contrast, no decrease in the titers was observed on cotton textiles containing zeolites alone (Zeo-textile). Neither cytopathic effects nor NP antigens were detected in MDCK cells inoculated with the H5N1 virus treated on the CuZeo-textile. The viral genes (H5, N1, M, and NP) were amplified from the virus treated on the CuZeo-textile by RT-PCR. The hemagglutinating activity of the CuZeo-textile treated virus was unaffected, indicating that virus-receptor interactions were maintained. Electron microscopic analysis revealed a small number of particles with morphological abnormalities in the H5N3 virus samples recovered immediately from the CuZeo-textile, while no particles were detectable in the 10-min treated sample, suggesting the rapid destruction of virions by the Cu(2+) in the CuZeo-textile. The loss of infectivity of H5 viruses could, therefore, be due to the destruction of virions by Cu(2+). Interestingly, CuCl(2) treatment (500 and 5000 μM) did not have an antiviral effect on the AF viruses (H5N1 and H5N3) even after 48 h of incubation, although the titer of the purified H5N3 virus treated with CuCl(2) declined greatly. The antiviral effect was inhibited by adding the AF to the purified H5N3 virus prior to the CuCl(2) treatment. The known antibacterial/antifungal activities of copper suggest that the CuZeo-textile can be applied at a high level of hygiene in both animals and humans.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22179064     DOI: 10.1016/j.antiviral.2011.11.017

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  24 in total

1.  Increased acid stability of the hemagglutinin protein enhances H5N1 influenza virus growth in the upper respiratory tract but is insufficient for transmission in ferrets.

Authors:  Hassan Zaraket; Olga A Bridges; Susu Duan; Tatiana Baranovich; Sun-Woo Yoon; Mark L Reed; Rachelle Salomon; Richard J Webby; Robert G Webster; Charles J Russell
Journal:  J Virol       Date:  2013-07-03       Impact factor: 5.103

2.  Wipes coated with a singlet-oxygen-producing photosensitizer are effective against human influenza virus but not against norovirus.

Authors:  Katharina Verhaelen; Martijn Bouwknegt; Saskia Rutjes; Ana Maria de Roda Husman; Erwin Duizer
Journal:  Appl Environ Microbiol       Date:  2014-05-09       Impact factor: 4.792

3.  Host Cell Copper Transporters CTR1 and ATP7A are important for Influenza A virus replication.

Authors:  Jonathan C Rupp; Manon Locatelli; Alexis Grieser; Andrea Ramos; Patricia J Campbell; Hong Yi; John Steel; Jason L Burkhead; Eric Bortz
Journal:  Virol J       Date:  2017-01-23       Impact factor: 4.099

4.  A molecular docking study repurposes FDA approved iron oxide nanoparticles to treat and control COVID-19 infection.

Authors:  Yasmin Abo-Zeid; Nasser S M Ismail; Gary R McLean; Nadia M Hamdy
Journal:  Eur J Pharm Sci       Date:  2020-07-12       Impact factor: 4.384

Review 5.  Opportunities for biomaterials to address the challenges of COVID-19.

Authors:  Daniel Chakhalian; Robert B Shultz; Catherine E Miles; Joachim Kohn
Journal:  J Biomed Mater Res A       Date:  2020-08-04       Impact factor: 4.854

6.  Advances in Antiviral Material Development.

Authors:  Lili Liang; Ashiq Ahamed; Liya Ge; Xiaoxu Fu; Grzegorz Lisak
Journal:  Chempluschem       Date:  2020-08-21       Impact factor: 3.210

7.  Saxifraga spinulosa-Derived Components Rapidly Inactivate Multiple Viruses Including SARS-CoV-2.

Authors:  Yohei Takeda; Toshihiro Murata; Dulamjav Jamsransuren; Keisuke Suganuma; Yuta Kazami; Javzan Batkhuu; Duger Badral; Haruko Ogawa
Journal:  Viruses       Date:  2020-06-28       Impact factor: 5.048

8.  Comparison of the antiviral effect of solid-state copper and silver compounds.

Authors:  Masafumi Minoshima; Yue Lu; Takuto Kimura; Ryuichi Nakano; Hitoshi Ishiguro; Yoshinobu Kubota; Kazuhito Hashimoto; Kayano Sunada
Journal:  J Hazard Mater       Date:  2016-03-09       Impact factor: 10.588

9.  High antiviral effects of hibiscus tea extract on the H5 subtypes of low and highly pathogenic avian influenza viruses.

Authors:  Tugsbaatar Baatartsogt; Vuong N Bui; Dai Q Trinh; Emi Yamaguchi; Dulyatad Gronsang; Rapeewan Thampaisarn; Haruko Ogawa; Kunitoshi Imai
Journal:  J Vet Med Sci       Date:  2016-05-19       Impact factor: 1.267

10.  Zinc-Embedded Polyamide Fabrics Inactivate SARS-CoV-2 and Influenza A Virus.

Authors:  Vikram Gopal; Benjamin E Nilsson-Payant; Hollie French; Jurre Y Siegers; Wai-Shing Yung; Matthew Hardwick; Aartjan J W Te Velthuis
Journal:  ACS Appl Mater Interfaces       Date:  2021-06-27       Impact factor: 9.229

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.